Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07599904 · ClinicalTrials.gov registry record
REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Recruiting
- Registry status
- 1,500
- Enrollment target
NCT07599904: Recruiting study, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT07599904 is a clinical trial that is actively recruiting participants, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 1,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07599904 is actively recruiting participants, sponsored by Medtronic Neurovascular Clinical Affairs.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
Study Summary
Post-Market Registry
Primary Outcome
Incidence of Safety Events of Interest through 90-day follow-up
Interventions
- PROCEDURE Device: Mechanical Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2026-06 |
| Est. Completion | 2031-07 |
What NCT07599904 shows while recruiting
NCT07599904 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Device: Mechanical Thrombectomy is the first listed.
NCT07599904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07599904 about?
NCT07599904 is a clinical study titled "REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)". Post-Market Registry
What is the current status of trial NCT07599904?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2026-06. Estimated completion is 2031-07.
What interventions are being tested in trial NCT07599904?
The interventions under investigation include: Device: Mechanical Thrombectomy (PROCEDURE).
Who is sponsoring clinical trial NCT07599904?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia